Issue: November 2012
November 01, 2012
1 min read
Save

CANVAS

Issue: November 2012
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Substudy of CANVAS evaluated the efficacy and tolerability of canagliflozin in insulin users with diabetes at elevated risk for CVD.

CANVAS